| Literature DB >> 27104569 |
Mirjana Andjelkovic1, Varvara Tsilia2, Andreja Rajkovic3, Koen De Cremer4, Joris Van Loco5.
Abstract
Staphylococcus aureus is one of the important aetiological agents of food intoxications in Europe and can cause gastro-enteritis through the production of various staphylococcal enterotoxins (SEs) in foods. Due to their stability and ease of production and dissemination, some SEs have also been studied as potential agents for bioterrorism. Therefore, specific and accurate analytical tools are required to detect and quantify SEs. Online solid-phase extraction liquid chromatography electrospray ionization tandem mass spectrometry (online SPE-LC-ESI-MS/MS) based on multiple reaction monitoring (MRM) was used to detect and quantify two types of SE (A and B) spiked in milk and buffer solution. SE extraction and concentration was performed according to the European Screening Method developed by the European Reference Laboratory for Coagulase Positive Staphylococci. Trypsin digests were screened for the presence of SEs using selected proteotypic heavy-labeled peptides as internal standards. SEA and SEB were successfully detected in milk samples using LC-MS/MS in MRM mode. The selected SE peptides were proteotypic for each toxin, allowing the discrimination of SEA and SEB in a single run. The detection limit of SEA and SEB was approximately 8 and 4 ng/g, respectively.Entities:
Keywords: SEA; SEB; Staphylococcus aureus enterotoxins; UPLC-ESI-MS/MS; milk
Mesh:
Substances:
Year: 2016 PMID: 27104569 PMCID: PMC4848643 DOI: 10.3390/toxins8040118
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Summary of tryptic peptides of SEB and SEA selected and evaluated for their use in the UPLC-ESI-MS/MS analysis.
| Toxin | Peptide Sequence | Peptide Study Code * | Position | Peptide Mass | Cone Voltage (V) | Collision Energy (eV) | ||
|---|---|---|---|---|---|---|---|---|
| SEA | YNLYNSDVFDGK | SEA-2 | 191–202 | K | 1434.654 | 722.0 > 474.40 | 25 | 33 |
| 722.0 > 391.30 | 25 | 23 | ||||||
| 722.0 > 278.20 | 25 | 23 | ||||||
| 722.0 > 212.20 | 25 | 23 | ||||||
| SELQGTALGNLK | SEA-4 | 40–51 | K | 1230.669 | 620.0 > 330.20 | 25 | 22 | |
| 620.0 > 217.20 | 25 | 20 | ||||||
| SEB | VLYDDNHVSAINVK | SEB-2 | 53–66 | K | 1586.817 | 798.2 > 692.30 | 25 | 15 |
| 798.2 > 213.30 | 25 | 15 | ||||||
| 798.2 > 185.20 | 25 | 31 | ||||||
| 532.6 > 185.20 | 25 | 31 | ||||||
| VTAQELDYLTR | SEB-5 | 182-192 | R | 1308.679 | 660.0 > 562.50 | 25 | 30 | |
| 660.0 > 919.60 | 25 | 20 | ||||||
| 660.0 > 790.60 | 25 | 20 | ||||||
| 660.0 > 677.50 | 25 | 20 | ||||||
| LGNYDNVR | SEB-6 | 85-92 | R | 950.469 | 481.0 > 847.50 | 25 | 15 | |
| 481.0 > 398.40 | 25 | 21 | ||||||
| 481.0 > 185.20 | 25 | 15 |
* Selected predicted peptide sequences of SEB (ETXB_STAAU) and SEA (ETXA_STAAU) after in silico digestions using PeptideMass software [25]. Only tryptic peptides (C-terminal K or R) without any missed cleavages are given. Mass is the monoisotopic mass of the uncharged peptide. ** Q1, quantifier and Q2 qualifier ion.
Qualitative results of the tested samples obtained by LC-MS/MS and following the modified criteria as explained in EU 2002/657.
| Sample (Matrix) | Test Portion Used (mL or g) | SEA Observed | SEB Observed | Peptide Observed (Study Code) | Actual Toxin Presencse * |
|---|---|---|---|---|---|
| B1 buffer sample spiked at | 100 µL | - | - | no | 0.5 ng SEB/g |
| B2 buffer sample spiked at | 100 µL | - | - | no | 2 ng SEB/g |
| M1 (milk) | 1 mL extract | - | - | no | No |
| M2 (milk) | 1 mL extract | - | ± | SEB-6 | 5 ng SEB/g |
| M3 (milk) | 1 mL extract | - | + | SEB-2 | 25 ng SEB/g |
| SEB-5 | |||||
| SEB-6 | |||||
| M4 (milk) | 1 mL extract | + | - | SEA-4 | 10 ng SEA/g |
| SEA-2 |
* The detection limit (LOD) of SEA and SEB was approximately 8 and 4 ng/g, respectively.
Figure 1MRM-MS spectra from quantitative analysis of SEB in milk sample (M2). Abbreviation E (endogenous) stands for the peptides observed in the unknown samples.
Figure 2MRM-MS spectra from quantitative analysis of SEA in milk sample (M4). Abbreviation E (endogenous) stands for the peptides observed in the unknown samples.
Figure 3Study protocol scheme whereby the samples were analysed by LC-MS/MS. The samples originated from the proficiency test (PT) organized in the scope of EQuATox project. * ESM: European Screening Method recommended by EURL for Coagulase Positive Staphylococci. The details of the method are explained in [15].